The Role of Vitamin D Deficiency in Predicting Peptic Ulcer Risk
DOI:
https://doi.org/10.36320/ajb/v17.i1.19178Keywords:
Vitamin D, H. pylori, Peptic Ulcer, and Gastrointestinal infectionsAbstract
Peptic ulcer continues to be a significant global health issue, largely due to Helicobacter pylori infection and vitamin D deficiency. H. pylori acts on mucosal damage through inflammation and increased gastric acid secretion, while vitamin D deficiency compromises immune defenses and hinders mucosal healing. The study aimed to assess the impact of vitamin D levels and H. pylori infection as predictive risk factors for peptic ulcer development. A total of 110 patients (aged 20–65) from the Gastroenterology Clinic in Babylon Province, Iraq, between March and October of 2024 were chosen for this cross-sectional study; they were categorized based on upper gastrointestinal endoscopic for peptic ulcer diagnosis and H. pylori status. A strong correlation was observed between H. pylori infection and PU (p = 0.001). Remarkably, vitamin D deficiency (<20 ng/mL) was highly significant (p < 0.001) and more distributed in patients with H. pylori Ve+ (84.3%) and displayed lower vitamin D levels (12.65 ng/mL) compared to H. pylori Ve- patients (39.0%) with levels of 17.37 (p = 0.017). Logistic regression analysis identified vitamin D deficiency as a strong independent risk factor for both H. pylori infection (OR = 8.41, 95% CI: 3.36–21.07) and progressive peptic ulcer (OR = 4.54, 95% CI: 1.92–10.72), p < 0.001. Conclusions: the crucial association of vitamin D deficiency with increased vulnerability to H. pylori infection as predicted factors in the progression of peptic ulcer risk. vitamin D screening in high-risk groups may well be an effective strategy for preventing peptic ulcer
Downloads
References
1. Albatineh, A. N., et al. (2023). Effect of vitamin D on Helicobacter pylori infection and eradication: An updated systematic review and meta-analysis. Journal of Preventive and Complementary Medicine, 2(3), 155–162. https://doi.org/10.22034/ncm.2023.385278.1074
2. Liu, D., Ren, L., Zhong, D., et al. (2023). Association of serum vitamin D levels on Helicobacter pylori infection: A retrospective study with real-world data. BMC Gastroenterology, 23, 391. https://doi.org/10.1186/s12876-023-03037-2 DOI: https://doi.org/10.1186/s12876-023-03037-2
3. Duan, Y., Xu, Y., Dou, Y., & Xu, D. (2025). Helicobacter pylori and gastric cancer: Mechanisms and new perspectives. Journal of Hematology & Oncology, 18(1), 10. https://doi.org/10.1186/s13045-024-01654-2 DOI: https://doi.org/10.1186/s13045-024-01654-2
4. Shafrir, A., Shauly-Aharonov, M., Katz, L. H., Paltiel, O., Pickman, Y., & Ackerman, Z. (2021). The association between serum vitamin D levels and Helicobacter pylori presence and eradication. Nutrients, 13(10), 4128. https://doi.org/10.3390/nu13010278 DOI: https://doi.org/10.3390/nu13010278
5. Wajid, S. K., & Sharba, I. R. (2024). Prediction of vitamin D and serotonin levels with increased risk of depression in adolescent students. BIO Web of Conferences, 108, 4009. https://www.bio-conferences.org/10.1051/bioconf/202410804009 DOI: https://doi.org/10.1051/bioconf/202410804009
6. Ali, A., & AlHussaini, K. I. (2024). Helicobacter pylori: A Contemporary Perspective on Pathogenesis, Diagnosis and Treatment Strategies. Microorganisms, 12(1), 222. https://doi.org/10.3390/microorganisms12010222 DOI: https://doi.org/10.3390/microorganisms12010222
7. Săsăran, M. O., Mărginean, C. O., Lupu, A., & Koller, A. M. (2023). Vitamin D and its association with H. pylori prevalence and eradication: A comprehensive review. Nutrients, 15(16), 3724. https://doi.org/10.3390/nu15163549 DOI: https://doi.org/10.3390/nu15163549
8. Hong, J., Gu, H., Lee, J., Lee, W., Chun, S., Han, K. H., et al. (2023). Intuitive modification of the Friedewald formula for calculation of LDL-cholesterol. Annals of Laboratory Medicine, 43(1), 29–37 https://doi.org/10.3343/alm.2023.43.1.29 DOI: https://doi.org/10.3343/alm.2023.43.1.29
9. Liu M, Gao H, Miao J, Zhang Z, Zheng L, Li F, Zhou S, Zhang Z, Li S, Liu H and Sun J (2024) Helicobacter pylori infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: a review. Front. Microbiol. 14:1330029. https://doi.org/10.3389/fmicb.2023.1330029 DOI: https://doi.org/10.3389/fmicb.2023.1330029
10. Amalia, R., Vidyani, A., I’tishom, R., Efendi, W. I., Danardono, E., Wibowo, B. P., et al. (2024). The prevalence, etiology, and treatment of gastroduodenal ulcers and perforation: A systematic review. Journal of Clinical Medicine, 13(4), 1063. https://doi.org/10.3390/jcm13041063 DOI: https://doi.org/10.3390/jcm13041063
11. Wang, S. E., Dashti, S. G., Hodge, A. M., Dixon-Suen, S. C., Castaño-Rodríguez, N., Thomas, R. J., et al. (2022). Mechanisms for the sex-specific effect of H. pylori on risk of gastroesophageal reflux disease and Barrett's esophagus. Cancer Epidemiology, Biomarkers & Prevention, 31(8), 1630–1637. https://doi.org/10.1158/1055-9965.epi-22-0234 DOI: https://doi.org/10.1158/1055-9965.EPI-22-0234
12. Yan, J., Yu, J., Bu, C., Yang, L., Chen, J., Ding, X., & Yuan, P. (2024). Antibiotic-Augmented Chemodynamic Therapy for Treatment of Helicobacter pylori Infection in the Dynamic Stomach Environment. Nano letters, 24(47), 14983–14992. https://doi.org/10.1021/acs.nanolett.4c03692 DOI: https://doi.org/10.1021/acs.nanolett.4c03692
13. Dias, S. P., Brouwer, M. C., & van de Beek, D. (2022). Sex and gender differences in bacterial infections. Infection and Immunity, 90(10), e00283-22. https://doi.org/10.1128/iai.00283-22 DOI: https://doi.org/10.1128/iai.00283-22
14. Vernon‐Roberts, A., Premaratne, M., Wright, R., Keenan, J. I., & Day, A. S. (2024). Profile of Helicobacter pylori infections among children in the South Island of New Zealand (2010–2021). Helicobacter, 29(1), e13037. https://doi.org/10.1111/hel.13037 DOI: https://doi.org/10.1111/hel.13037
15. Skokowski, J., Vashist, Y., Girnyi, S., Cwalinski, T., Mocarski, P., Antropoli, C., et al. (2024). The aging stomach: Clinical implications of H. pylori infection in older adults—Challenges and strategies for improved management. International Journal of Molecular Sciences, 25(23), 12826. https://doi.org/10.3390/ijms252312826 DOI: https://doi.org/10.3390/ijms252312826
16. Carvalho, T., Vieira Costa, F., Santos, S. R., Costa, D., Fernandes, D., & Caetano, A. C. (2024). Helicobacter pylori infection and peptic ulcer disease in patients with advanced chronic liver disease. Frontline Gastroenterology.
https://doi.org/10.1136/flgastro-2024-102944 DOI: https://doi.org/10.1136/flgastro-2024-102944
17. Ibrahim, T., Russel, W., Getachew, A., Zemene, E., Cheneke, W., & Taye, B. (2024). Association between infection with Helicobacter pylori and metabolic syndrome among diabetic patients attending Jimma medical center in Jimma city, Ethiopia: a cross-sectional study. BMC infectious diseases, 24(1), 922. https://doi.org/10.1186/s12879-024-09840-w DOI: https://doi.org/10.1186/s12879-024-09840-w
18. Huang, J., Zhang, K., Wang, F., & Tang, X. (2023). The associations between Helicobacter pylori immunoglobulin G seropositivity and body mass index in adults. BMC Infectious Diseases, 23(1), 485 https://doi.org/10.1186/s12879-023-08427-1 DOI: https://doi.org/10.1186/s12879-023-08427-1
19. Ma, P. F., Zhuo, L., Yuan, L. P., & Qi, X. H. (2024). Recent Advances in Vitamin D3 Intervention to Eradicate Helicobacter pylori Infection. Journal of multidisciplinary healthcare, 17, 825–832. https://doi.org/10.2147/JMDH.S454605 DOI: https://doi.org/10.2147/JMDH.S454605
20. Zhang, M., Liu, T., Luo, L., Zhang, Y., Chen, Q., Wang, F., & Xie, Y. (2024). Common diagnostic biomarkers and molecular mechanisms of Helicobacter pylori infection and inflammatory bowel disease. Frontiers in immunology, 15, 1492810. https://doi.org/10.3389/fimmu.2024.1492810 DOI: https://doi.org/10.3389/fimmu.2024.1492810
21. Guo, L., Chen, W., Zhu, H., Chen, Y., Wan, X., Yang, N., Xu, S., Yu, C., & Chen, L. (2014). Helicobacter pylori induces increased expression of the vitamin d receptor in immune responses. Helicobacter, 19(1), 37–47. https://doi.org/10.1111/hel.12102 DOI: https://doi.org/10.1111/hel.12102
22. Izquierdo, M. J., Cavia, M., Muñiz, P., et al. (2012). Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients. BMC Nephrology, 13, 159. https://doi.org/10.1186/1471-2369-13-159 DOI: https://doi.org/10.1186/1471-2369-13-159
23. Wang, T. T., Nestel, F. P., Bourdeau, V., Nagai, Y., Wang, Q., Liao, J., Tavera-Mendoza, L., Lin, R., Hanrahan, J. W., Mader, S., & White, J. H. (2004). Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. Journal of immunology (Baltimore, Md. : 1950), 173(5), 2909–2912. https://doi.org/10.4049/jimmunol.173.5.2909 DOI: https://doi.org/10.4049/jimmunol.173.5.2909
Downloads
Published
Issue
Section
License
Copyright (c) 2025 intisar .sharba, Zahraa Majid Abd-Alameer
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
